Description of Collaborative Activity: |
As part of its continued effort to support awardee companies' journey to commercialization, NCI SBIR Development Center hosted a specialized workshop for awardee companies developing molecularly targeted radiotherapy. The Workshop on Facilitating the Development of Molecularly Targeted Radiotherapy (hereinafter TRT Workshop) brought together experts from the SBIR program, NCI Radiation Research program, Food and Drug Administration's Center for Drug Evaluation and Research (FDA CDER), and Department of Energy's Isotope program to introduce the regulatory and clinical processes relevant to workshop participants. |
